Who is sponsoring NCT01002443?

NCT01002443 is sponsored by National Cancer Center, Korea.

What condition does NCT01002443 study?

NCT01002443 studies Gastric Cancer.

What drugs are being tested in NCT01002443?

Interventions: Helicobacter pylori eradication, placebo.

What is the status of NCT01002443?

NCT01002443 is currently COMPLETED.

Last reviewed 2009-10-26 · How we verify

Effect of Helicobacter Pylori Eradication on Glandular Atrophy and Intestinal Metaplasia in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer

NCT01002443 Phase 2 COMPLETED

Helicobacter pylori (H. pylori) is associated with gastric cancer in epidemiological studies.Gastric atrophy and intestinal metaplasia caused by H. pylori are considered as precancerous lesions, but whether H. pylori eradication improves these lesions is controversial.The primary objective of this study is to evaluate whether Helicobacter pylori eradication improves glandular atrophy and intestinal metaplasia which are known to be precancerous condition in patients undergoing subtotal gastrectomy for gastric cancer.

Details

Lead sponsor	National Cancer Center, Korea
Phase	Phase 2
Status	COMPLETED
Enrolment	190
Start date	2003-07
Completion	2009-03

Conditions

Gastric Cancer

Interventions

Helicobacter pylori eradication
placebo

Primary outcomes

Histological grading improvement rate — 6 years

Countries

South Korea